Novo Nordisk A/S vs Warner Music Group Corp — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Warner Music Group Corp trades at $28.2 (market cap $14.64B). The key difference: Novo Nordisk A/S is far larger — about 15.1× Warner Music Group Corp's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | WMG | |
|---|---|---|
Market Cap | $220.53B | $14.64B |
Sector | Health | Media |
52-Week High | $71.70 | $34.72 |
52-Week Low | $35.29 | $23.65 |
Enterprise Value | $239.49B | $18.84B |
Dividend Yield | 3.63% | 2.71% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →